Translational Cancer Observational Protocol
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS San Raffaele
About this trial
Observational study on relapse occurrence and on the quality of life in patients who underwent nephroureterectomy surgery
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18 years or older
Upper tract urothelial cancer diagnosis
Indication to cancer removal through nephroureterectomy surgery
Ability to read and sign the informed consent
Disqualifiers
Age < 18 years
Absence of upper tract urothelial cancer
Inability to read and sign the informed consent
Trial population
Patients with upper tract urothelial cancer who underwent nephroureterectomy surgery.
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Nephroureterectomy
Procedure/SurgeryRemoval of cancer mass by urether and kidney complete resection.
Treatment groups
1,250 Participants
are divided into 1 treatment groupGroup A: Experimental1 intervention
Trial outcomes
Primary outcomes
1
Clinical progression data collection
Collection intended for the purpose of implementing diagnostic and therepautic strategies for the management of the disease in both the patient enrolled in the study and for future cases. Data will be collected in a dedicated internal database by means of medical records obtained during the patients' stay in the hospital and during follow up visits. The data collected includes anamnesis, data regarding surgery, laboratory exam and imaging exams.
Time frame
50 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov